您的当前位置:首页 > 行业数据 > LM-108是全球/中国研发进度最快的CCR8靶向药物
图片属性
图片格式:PNG 图片大小:258KB 图片尺寸:2349*1266
同报告图片
 / 4
LM-108是全球/中国研发进度最快的CCR8靶向药物_第1页
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
LM-108是全球/中国研发进度最快的CCR8靶向药物_第2页
LM-108是全球/中国研发进度最快的CCR8靶向药物_第3页
LM-108是全球/中国研发进度最快的CCR8靶向药物_第4页
LM-108是全球/中国研发进度最快的CCR8靶向药物_第5页
所属报告: 【国金证券】传统Pharma龙头加速创新转型,拓展全球布局-250922(46页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠